Copyright © 2020 Elsevier Inc. All rights reserved.
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 219(2020) vom: 01. Okt., Seite 108555
|
|---|
| Auteur principal: |
Laurence, Jeffrey
(Auteur) |
|---|
| Autres auteurs: |
Mulvey, J Justin,
Seshadri, Madhav,
Racanelli, Alexandra,
Harp, Joanna,
Schenck, Edward J,
Zappetti, Dana,
Horn, Evelyn M,
Magro, Cynthia M |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2020
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Case Reports
Journal Article
Research Support, Non-U.S. Gov't
COVID-19
Complement
Coronavirus
Eculizumab
Lectin pathway
MASP2
Antibodies, Monoclonal, Humanized
plus...
Biomarkers
Complement C5
Complement Inactivating Agents
Complement Membrane Attack Complex
Fibrin Fibrinogen Degradation Products
Peptide Fragments
fibrin fragment D
Complement C4b
80295-50-7
complement C4d
80295-52-9
eculizumab
A3ULP0F556
MASP2 protein, human
EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases |
|---|